Header cover image

Norwegian (OSEAX) Biotech Industry Analysis

UpdatedMar 27, 2024
DataAggregated Company Financials
Companies11
  • 7D3.6%
  • 3M-41.9%
  • 1Y-68.8%
  • YTDn/a

Last week, the Biotech industry hasn't moved much but Nykode Therapeutics is up 7.0% in that time. Unfortunately though, the industry is down 69% over the past 12 months. In the next few years, earnings are forecast to decline by 8.4% annually.

Industry Valuation and Performance

Has the Norwegian Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 27 Mar 2024kr9.3bkr657.2m-kr940,879,168.4241x-9.8x14.1x
Fri, 23 Feb 2024kr15.3bkr671.9m-kr1,003,580,148.1841x-15.2x22.8x
Sun, 21 Jan 2024kr16.2bkr657.0m-kr1,360,612,103.0059.2x-11.9x24.6x
Tue, 19 Dec 2023kr16.1bkr655.7m-kr1,356,941,061.0058.4x-11.9x24.6x
Thu, 16 Nov 2023kr14.8bkr638.2m-kr1,449,531,191.0056.4x-10.2x23.2x
Sat, 14 Oct 2023kr15.0bkr627.7m-kr1,466,768,547.0048.7x-10.2x23.9x
Mon, 11 Sep 2023kr15.4bkr624.2m-kr1,458,262,860.0056.2x-10.6x24.7x
Wed, 09 Aug 2023kr16.0bkr556.7m-kr1,458,428,651.0054x-11x28.8x
Fri, 07 Jul 2023kr14.9bkr562.0m-kr1,480,213,856.0058.7x-10.1x26.5x
Sun, 04 Jun 2023kr17.1bkr564.9m-kr1,501,010,401.0061.8x-11.4x30.3x
Tue, 02 May 2023kr16.7bkr541.4m-kr1,443,997,464.0030.6x-11.6x30.9x
Thu, 30 Mar 2023kr15.0bkr536.0m-kr1,554,552,833.0030.3x-9.6x27.9x
Sat, 25 Feb 2023kr17.0bkr831.4m-kr1,436,800,870.0032.2x-11.9x20.5x
Mon, 23 Jan 2023kr17.9bkr807.6m-kr1,393,522,266.0024.7x-12.8x22.1x
Wed, 21 Dec 2022kr19.5bkr808.5m-kr1,394,036,135.0040.8x-14x24.1x
Fri, 18 Nov 2022kr18.2bkr818.1m-kr1,358,639,538.0035.4x-13.4x22.2x
Sun, 16 Oct 2022kr17.4bkr816.3m-kr1,365,579,860.0036.5x-12.7x21.3x
Tue, 13 Sep 2022kr20.7bkr785.1m-kr1,364,663,043.0037.9x-15.1x26.3x
Thu, 11 Aug 2022kr22.1bkr756.7m-kr1,377,473,984.0046.4x-16x29.2x
Sat, 09 Jul 2022kr20.0bkr776.9m-kr1,382,992,728.0044.8x-14.4x25.7x
Mon, 06 Jun 2022kr21.4bkr1.1b-kr1,031,298,656.0039.7x-20.8x19.8x
Wed, 04 May 2022kr23.4bkr1.1b-kr989,703,963.0042.4x-23.7x22x
Fri, 01 Apr 2022kr26.8bkr2.7bkr390.8m9.9x68.5x10x
Sun, 27 Feb 2022kr26.6bkr2.7bkr431.0m10.2x61.7x9.9x
Tue, 25 Jan 2022kr31.0bkr2.2bkr77.7m34.3x399.1x13.9x
Thu, 23 Dec 2021kr40.5bkr2.2bkr55.9m41.8x723.2x18.4x
Sat, 20 Nov 2021kr37.1bkr2.6bkr496.3m14.7x74.7x14x
Mon, 18 Oct 2021kr37.7bkr2.5bkr453.8m15.8x83x14.9x
Wed, 15 Sep 2021kr39.1bkr2.6bkr508.1m16.6x77x15.2x
Fri, 13 Aug 2021kr39.3bkr2.6bkr508.1m16.8x77.3x15.3x
Tue, 08 Jun 2021kr42.3bkr2.5bkr545.4m20x77.6x16.7x
Price to Earnings Ratio

71.9x


Total Market Cap: kr39.2bTotal Earnings: kr545.4mTotal Revenue: kr2.5bTotal Market Cap vs Earnings and Revenue0%0%0%
Norwegian Biotech Industry Price to Earnings3Y Average 51.9x202220232024
Current Industry PE
  • Investors are pessimistic on the Norwegian Biotechnology industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 21.5x is higher than the industry's current PS ratio of 13.8x.
Past Earnings Growth
  • Total earnings for the Biotechnology industry have declined over the last three years, with the industry now making a loss overall.
  • Revenues have also declined 36% per year, which is driving profits down.

Industry Comparison

How does Norwegian Biotech compare with similar industries?

NO Market1.26%
Healthcare0.83%
Biotech3.65%
Biotech3.65%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
NYKD Nykode Therapeuticskr15.248.2%
+kr375.5m
-27.5%PS34.7x
BGBIO BerGenBiokr0.187.6%
+kr34.4m
-96.3%PS1373.2x
AZT ArcticZymes Technologieskr29.452.1%
+kr30.5m
-23.3%PE80x
TRMED Thor Medicalkr1.0311.1%
+kr24.1m
n/aPB0.9x
ULTI Ultimovacskr7.697.1%
+kr17.5m
-93.2%PB0.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

HBC

kr2.10

Hofseth BioCare

7D

-8.7%

1Y

-27.3%

CRNA

kr6.00

Circio Holding

7D

-14.0%

1Y

-71.8%

NYKD

kr15.24

Nykode Therapeutics

7D

8.2%

1Y

-27.5%

EXTX

kr6.45

EXACT Therapeutics

7D

-17.3%

1Y

-55.5%

ULTI

kr7.69

Ultimovacs

7D

7.1%

1Y

-93.2%

ABS

kr9.50

Arctic Bioscience

7D

-6.9%

1Y

-13.6%

LYTIX

kr6.30

Lytix Biopharma

7D

-5.3%

1Y

-3.1%

TRMED

kr1.03

Thor Medical

7D

11.1%

1Y

n/a

BGBIO

kr0.18

BerGenBio

7D

7.6%

1Y

-96.3%

PCIB

kr1.65

PCI Biotech Holding

7D

-3.1%

1Y

-19.6%

NANOV

kr2.00

Nordic Nanovector

7D

-18.3%

1Y

-22.2%